2018
DOI: 10.20450/mjcce.2018.1471
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of a forced degradation study of atorvastatin employing an experimental design approach

Abstract: This study involved the optimization of experimental conditions for the forced degradation of atorvastatin employing the experimental design (DoE) approach, as a scientific multifactorial strategy. Using 2n full factorial design, stress conditions of oxidative, hydrolytic and thermal degradation were optimized to obtain a targeted level of atorvastatin degradation. Atorvastatin and all related and degradation products were separated on Poroshell 120 EC C18 50 ´ 3.0 mm 2.7 μm, using 10 mM ammonium formate and a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…The European Pharmacopoeia monograph of Atorvastatin calcium trihydrate 1 prescribes the HPLC method for impurities testing of atorvastatin active substance using an octylsilyl C8 column and a mobile phase composed of acetonitrile, tetrahydrofuran and ammonium acetate buffer adjusted to pH 5.0 with glacial acetic acid. There are also a few published HPLC analytical methods for the quantification of atorvastatin and its impurities using a C18 or C8 column, with tetrahydrofuran in the mobile phase composition, [15][16][17][18][19][20] which was to be avoided in our research due to its toxicity and instability. The method published by Vukkum 20 using simple gradient elution with 0.1 % trifluoroacetic acid and acetonitrile and a Zorbax Bonus RP column, reported good resolution between critical pairs in a short run time of 25 min.…”
Section: Methods Development and Optimizationmentioning
confidence: 99%
See 1 more Smart Citation
“…The European Pharmacopoeia monograph of Atorvastatin calcium trihydrate 1 prescribes the HPLC method for impurities testing of atorvastatin active substance using an octylsilyl C8 column and a mobile phase composed of acetonitrile, tetrahydrofuran and ammonium acetate buffer adjusted to pH 5.0 with glacial acetic acid. There are also a few published HPLC analytical methods for the quantification of atorvastatin and its impurities using a C18 or C8 column, with tetrahydrofuran in the mobile phase composition, [15][16][17][18][19][20] which was to be avoided in our research due to its toxicity and instability. The method published by Vukkum 20 using simple gradient elution with 0.1 % trifluoroacetic acid and acetonitrile and a Zorbax Bonus RP column, reported good resolution between critical pairs in a short run time of 25 min.…”
Section: Methods Development and Optimizationmentioning
confidence: 99%
“…As a hydrophobic molecule, mostly columns recommended for the evaluation of Atorvastatin impurity profile are C18 or C8. [15][16][17][18][19][20] However, the overlapping peaks co-eluting with impurity B during the predictive stability indicating experiments could not be separated using the commonly used methods on C8 and C18 columns.…”
Section: Introductionmentioning
confidence: 99%